LH | Laboratory of America Holdings
224.44 -5.35 (-2.33%)
LH Price Profile
Open
$226.89
CLOSE
$224.44
DAY RANGE
222.55 - 228.28
52 WEEK RANGE
222.55 - 317.17
MARKET CAP
25.53B
Trading volume
201.72K
Prev. Close
229.79
50 Day MA
290.94
Shares Outstanding
95.7M
Public Float
95.16M
Average Volume
1.01M
Beta
1.03
PEG Ratio
-1.31
Shares Shorted
1.83M
% OF SHARES SHORTED
2.15%
Short Ratio
2.04
1 Year Performance
24.78%
Diluted EPS (TTM)
28.19
Q Revenue Growth
0.04
Ebitda
4.63B
Gross Profit (TTM)
5.01B
Total Cash (MRQ)
2.06B
Total Debt (MRQ)
6.34B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Laboratory of America Holdings (LH) company profile
Laboratory Corp. of America Holdings (NYSE: LH) is a life sciences company offering clinical laboratory and end-to-end drug development services. Its services and products aim to advance patient health and power clear, confident decisions through its diagnostics. It operates through the segments of Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD), serving doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers.
